• Sign up
  • Log in
  • Basket: (0 items)
Duchenne UK
We fund more research than anyone else
  • Duchenne Direct
  • Donate
  • Twitter
Skip over main navigation Menu
  • About Duchenne
    • What is Duchenne
    • Diagnosing Duchenne
    • Newly Diagnosed
    • Stages Of Duchenne
    • Patient and Parent Stories
    • Current Drugs For Duchenne
    • Supporting Therapies
    • Treatments In The Pipeline
    • Clinical Trial Finder
    • Understanding Clinical Trials
  • What We Do
    • Our Mission
    • Our Impact
    • Funding Research & Trials
    • Accelerating Drug Timeline
    • Community Engagement
    • DMD Hub
    • Project HERCULES
    • Our Information Days
    • News
  • About Us
    • Meet The Team
    • President & Patrons
    • Scientific Advisory Board
    • Patient Advisory Board
    • Donor Advisory Board
    • Trustees
    • Joining Jack
    • Alex's Wish
    • Duchenne Now
    • Watch Our Film
  • Support Duchenne UK
    • How You Can Help
    • Why Support Us?
    • Family and Friends Funds
    • Duchenne Direct
    • Fundraising Events
    • World's Strongest Boys
    • Duchenne Dash
    • Corporate Support
  • News
  • Admin
    • Log in
  • Basket: (0 items)

Test page 1st March

Published: 1st March, 2016

Author: Duchenne UK

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Eight pharmaceutical industry leaders join Phase 2 of Project HERCULES

    Duchenne UK are delighted to announce that eight industry partners are supporting Phase 2 of Project HERCULES in 2019.

  • Ralphy's Fund

    We have set ourselves a target to raise awareness and as much money as we can to help fund research to find a cure for this cruel disease.

  • Wheels of Change: BUILDING THE DREAM CHAIR

    We partnered with Whizz-Kidz and the University of Edinburgh to win £1 million from the People’s Postcode Lottery Dream Fund to develop a dream chair for wheelchair users. Read this update from WhizzKidz

  • Duchenne UK Grants a further £780,000 to Tamoxifen Open Label Extension Study

    Open Label Extension Study will give all patients on the TAMDMD trial access to Tamoxifen after completing trial. Total funding commitment to the TAMDMD trial now stands at £1.4million.

Most read

  • Duchenne Dash 2019

    London to Paris in 24 hours, by bike! Please contact us to register interest for 2019 [email protected]

  • Meet The Team

    Our co-founders Alex Johnson and Emily Crossley met after their sons were diagnosed with Duchenne muscular dystrophy. They both set up charities, Alex with Joining Jack, Emily with the Duchenne Children’s Trust.

  • Girls living with Duchenne

    Duchenne affects approximately 1 in every 3,500 boys that are born but only around 1 in every 50 million girls. It may be rare, but it does happen. We have been speaking to Feriel, a 26 year old woman living with Duchenne muscular dystrophy. She has written us a short blog about her experiences with Duchenne from diagnosis to now.

  • Gene Therapy Overview

    An exciting new gene-based therapy on the horizon

  • Understand Duchenne

    Find out more about DMD and how we can help you

  • What Are The Stages Of Duchenne?

  • The Impact Of Brexit On Rare Diseases

    Please read and share our paper on the impact of Brexit on rare diseases.

  • Welcome To Duchenne UK

    Duchenne Children's Trust and Joining Jack have joined forces to create Duchenne UK, dedicated to funding and accelerating treatments for Duchenne Muscular Dystrophy.

  • Diet

    A healthy diet is vital for patients with DMD, especially foods high in Vitamin D and calcium

  • How You Can Help

    Join Us to End Duchenne

DMD Hub

Expanding Clinical trial capacity Read more

Published: 1st March, 2015

Updated: 30th July, 2018

Author: Duchenne UK

Related topics:
  • Accelerating Drug Development

How You Can Help

Join Us to End Duchenne Read more

Published: 8th March, 2016

Updated: 6th September, 2018

Author: Duchenne UK

Our Impact

How we are making a difference Read more

Published: 9th March, 2016

Updated: 4th September, 2018

Author: Duchenne UK

Related topics:
  • About Us
  • What We Do

OUR INFORMATION DAYS

Please join us at our free Patient Information Day Read more

Published: 27th July, 2017

Updated: 8th October, 2018

Author: Duchenne UK

Comments: 1

Related topics:
  • Community Engagement and Support

Our Mission To End Duchenne

Duchenne UK has a clear vision; to fund and accelerate treatments and a cure for DMD Read more

Published: 4th October, 2017

Updated: 3rd September, 2018

Author: Duchenne UK

Related topics:
  • What We Do

Latest tweet

Sign up for our newsletter

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • Youtube

Contact UsPrivacy Policy

Registered Charity No. 1147094. © 2016 Duchenne UK. All rights reserved.
A non profit company limited by guarantee. Registered in England No. 8030768

Duchenne UK, 56 Wood Lane, London, W12 7SB.

We will always store your personal details securely. We’ll use them to provide the service that you have requested, and communicate with you in the way(s) that you have agreed to. Your data may also be used for analysis purposes, to help us provide the best service possible. For full details see our Privacy Policy or contact us on [email protected]